-
T627127-250mg(R)-2-Aminomethyl-4-Boc-morpholine.
-
T627127-100mg(R)-2-Aminomethyl-4-Boc-morpholine.
-
T614389-1mgTesevatinib (XL-647: EXEL-7647: KD-019) is a multi-target tyrosine kinase inhibitor: inhibits EGFR, ErbB2, KDR, Flt4 and EphB4 kinase with IC50s of 0.3, 16, 1.5, 8.7, and 1.4 nM.
-
T614389-10mgTesevatinib (XL-647: EXEL-7647: KD-019) is a multi-target tyrosine kinase inhibitor: inhibits EGFR, ErbB2, KDR, Flt4 and EphB4 kinase with IC50s of 0.3, 16, 1.5, 8.7, and 1.4 nM.
-
T614382-1mgTerevalefim (ANG-3777), an hepatocyte growth factor (HGF) mimetic, selectively activates the c-Met receptor.
-
T614382-10mgTerevalefim (ANG-3777), an hepatocyte growth factor (HGF) mimetic, selectively activates the c-Met receptor.
-
T595346-5gt-Boc-N-amido-PEG3-CH2CO2H is a PEG derivative containing a terminal carboxylic acid and Boc-protected amino group. The hydrophilic PEG spacer increases solubility in aqueous media. The terminal carboxylic acid can be reacted with primary amine
-
S742395-500mlSodium oxalate standard solution.
-
S742368-500mlSalicylic acid standard solution.
-
S742344-500mlSulfate standard solution.
-
S742311-500mlSodium standard.
-